Showing results (241-250 of 374) with videos related to
Sort By:
Pageof 38
Breast Cancer : Basic and Clinical Research|September 30, 2015
Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic OpportunitiesEthan Rothschild, Debabrata BanerjeeBreast Cancer : Basic and Clinical Research|August 27, 2015
Incidence and Potential Significance of Internal Mammary Lymphadenopathy on Computed Tomography in Patients with a Diagnosis of Primary Breast CancerSarah L Savaridas, Jonathan D Spratt, Julie CoxBreast Cancer : Basic and Clinical Research|November 18, 2017
Application of Breast Ultrasound Elastography to Differentiate Intracapsular Collection from Silicone-Induced Granuloma of Breast Implant Capsule Complementarily to Contrast-Enhanced Breast Magnetic Resonance ImagingEduardo de Faria Castro Fleury, Ana Claudia Gianini, Veronica Ayres, et al.Breast Cancer : Basic and Clinical Research|July 8, 2016
Increasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and TreatmentVenkata Ramana Kotamraju, Shweta Sharma, Poornima Kolhar, et al.Breast Cancer : Basic and Clinical Research|February 14, 2018
Breast Cancer Survivors, Common Markers of Inflammation, and Exercise: A Narrative ReviewRobert Coleman MillsBreast Cancer : Basic and Clinical Research|November 2, 2019
The Study of Validity and Reliability of the SPOFIA Scale in Patients With Postoperative Breast CancerHavva Bozdemir, Dilek AyginBreast Cancer : Basic and Clinical Research|July 7, 2009
Cost-effective screening for breast cancer worldwide: current state and future directionsA Sarvazyan, V Egorov, J S Son, et al.Breast Cancer : Basic and Clinical Research|August 11, 2010
Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast CancerTirtsa Porrata-Doria, Jaime L Matta, Summer F AcevedoBreast Cancer : Basic and Clinical Research|December 11, 2012
Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?Summer F AcevedoBreast Cancer : Basic and Clinical Research|December 11, 2012
Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues Regarding Dual HER2-Targeted TherapyEugene R Ahn, Emilie Wang, Stefan GlückPageof 38